| Brian Zwahlen, DDS | |
|
201 E Orangeburg Ave Ste C, Modesto, CA 95350-5355 | |
| (209) 522-5102 | |
| (209) 522-1051 |
| Full Name | Brian Zwahlen |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 201 E Orangeburg Ave Ste C, Modesto, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447384102 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 47683 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Brian Zwahlen, DDS 201 E Orangeburg Ave Ste C, Modesto, CA 95350-5355 Ph: (209) 522-5102 | Brian Zwahlen, DDS 201 E Orangeburg Ave Ste C, Modesto, CA 95350-5355 Ph: (209) 522-5102 |
News Archive
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the New Drug Application (NDA) for BYDUREON™ (exenatide extended-release for injectable suspension).
Survivorship care plans are an important tool to help cancer survivors transition out of active treatment and back to their regular lives, but a new study found that a number of vulnerable groups are not receiving those plans.
"At first glance, the new Pre-existing Condition Insurance Plan sounds like welcome relief for jobless Illinoisans who have serious medical issues and are struggling with the loss of employer financed health care. The federally financed $5 billion plan $196 million of which is earmarked for Illinois provides an affordable health insurance option to people who previously were limited to the far more expensive, state run Illinois Comprehensive Health Insurance Plan.
Proving the benefits and cost-effectiveness of animal robots in the treatment of dementia is the focus of a Griffith research study.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Olanzapine Tablets USP, 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, and 20 mg.
› Verified 3 days ago
Bhavini Harish Shelat, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 2801 Coffee Rd, Building B, Modesto, CA 95355 Phone: 209-727-4296 | |
Dr. Martha L Gomez, D.D.S Dentist Medicare: Not Enrolled in Medicare Practice Location: 1130 Coffee Rd, Suite 9a, Modesto, CA 95355 Phone: 209-522-8783 Fax: 209-526-1470 | |
Saliem Melles Tsighe, D.M.D Dentist Medicare: Medicare Enrolled Practice Location: 2200 Mchenry Ave Ste B, Modesto, CA 95350 Phone: 209-526-9132 | |
Dr. John R Jeppson, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1429 College Ave, Suite G, Modesto, CA 95350 Phone: 209-526-0344 Fax: 209-526-0370 | |
Dr. Samuel Ernest Bleakley, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1601 Mchenry Village Way Ste 1, Modesto, CA 95350 Phone: 209-577-1313 Fax: 209-577-8584 | |
Efraim Sanson Florendo, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 2605 Coffee Rd, Modesto, CA 95055 Phone: 209-521-0100 | |
Lynn Zwahlen, DDS Dentist Medicare: Medicare Enrolled Practice Location: 201 E Orangeburg Ave Ste C, Modesto, CA 95350 Phone: 209-522-5761 Fax: 209-522-1051 |